Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: A case report

Rheumatology International

Volumn 28, Issue 4, 2008, Pages 385-386

  Caramaschi, Paola ^a   Volpe, Alessandro ^a   Carletto, Antonio ^a   Bambara, Lisa Maria ^a   Biasi, Domenico ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Anti Scl70 antibody; Nailfold videocapillaroscopy; Systemic sclerosis

Indexed keywords

CYCLOPHOSPHAMIDE; ILOPROST; METHOTREXATE; METHYLPREDNISOLONE; SCL 70 ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HUMAN; IMMUNOFLUORESCENCE; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; LOWER ESOPHAGUS SPHINCTER; LUNG FUNCTION TEST; MALE; POLYARTHRITIS; PRIORITY JOURNAL; SKIN DISEASE; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

ADULT; AUTOANTIBODIES; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROSCOPIC ANGIOSCOPY; NUCLEAR PROTEINS; SCLERODERMA, SYSTEMIC; SKIN ULCER; TREATMENT OUTCOME;

EID: 38049045590     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0434-2     Document Type: Article

References (9)

1. Derk CT, Jimenez SA (2003) Systemic sclerosis: current view of its pathogenesis. Autoimmun Rev 2:181-191
2. Walker UA, Tyndall A, Czirjak L, Denton C., Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M and EUSTAR Co-authors (2007) Clinical risk assessment of organ manifestations in systemic sclerosis-a report from the EULAR Scleroderma Trials and Research (EUSTAR) group data base. Ann Rheum Dis 66:754-763
3. Jacobsen S, Ullman S, Shen GQ, Wiik A, Haberq P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454-2459
4. Diot E, Giraudeau B, Diot P, Degenee D, Ritz L, Guilmot JL, Lemarie E (1999) Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest 116:715-720
5. Steen VD (2005) Autoantibodies in systemic sclerosis. Seminars Arthritis Rheum 35:35-42
6. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719-726
7. Hu PQ, Fertig N, Medsger TA Jr, Wright TM (2003) Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 48:1363-1373
8. Hénault J, Tremblay M, Clément I, Raymond Y, Senécal Y (2004) DNA binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 50:3265-3274
9. Hénault J, Robtaille G, Senécal Y (2006) DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I antibodies from systemic sclerosis patients. Arthritis Rheum 54:963-973